A lot of people across the world have got very sick due to COVID infection, and over 5.9 million individuals died as a result of it. The number is low compared to the total number of infections with the coronavirus (more than 425.8 million worldwide), but the news remains terrifying by itself. The USA remains the hardest-hit country by the ongoing pandemic, as it counts over 80 million infections and more than 959,000 deaths. The numbers are revealed by worldometers.info.
Surely the world would use more ways of not developing severe illness as a result of COVID infection. Some were relying on ivermectin, but a new study confirms that the drug is not efficient.
Almost 500 individuals were enrolled
The new study enrolled hundreds of people, and they all had the right ages and underlying health conditions to be at risk of severe COVID illness. For five days, half of the group were treated with high doses of ivermectin administered orally. The other half received other forms of treatment for their symptoms.
The outcomes of the two groups turned out to be quite the same. Furthermore, people who took ivermectin had to deal with more side effects than the individuals who didn’t, and they were quite severe sometimes. Heart attacks and diarrhea were among those side effects.
Lim, who’s an infectious disease specialist from the Raja Permaisuri Bainun Hospital in Perak (Malaysia), declared as CNN quotes:
The public should understand that the highly touted safety profile of ivermectin is related to its use as an anti-parasitic drug. The use of ivermectin as an antiviral in COVID-19 is a totally different ball game, with notable differences in dosing, duration and mechanism of actions.
The new study was published in the journal JAMA Internal Medicine.